MPM BIOIMPACT LLC

13F Portfolio Filings

Most recent 13F
Q3 2024
Location
Boston, MA
CIK
0001687078
Alternate names
BioImpact Capital LLC, MPM Oncology Impact Management LP, MPM ONCOLOGY IMPACT MANAGEMENT, L.P.
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q3 2024 43 666,570 CGEM, INSM, OLMA, RNA 13F-HR 11/12/2024 000095012324011026
Q2 2024 44 643,506 CGEM, INSM, OLMA, ITOS 13F-HR 8/14/2024 000095012324008626
Q1 2024 38 621,981 CGEM, GERN, IOVA, ZNTL 13F-HR 5/15/2024 000095012324005704
Q4 2023 32 427,428 CGEM, IOVA, OLMA, GERN 13F-HR 2/13/2024 000095012324001863
Q3 2023 32 374,602 CGEM, OLMA, GERN, RPTX 13F-HR 11/14/2023 000095012323010967
Q2 2023 34 496,602 CGEM, ISEE, KDNY, GERN 13F-HR 8/14/2023 000095012323007806
Q1 2023 31 384,916 CGEM, PRVB, ISEE, ITOS 13F-HR 5/12/2023 000095012323004668
Q4 2022 33 385,456 CGEM, ITOS, INBX, RPTX 13F-HR 2/14/2023 000095012323002440
Q3 2022 38 422,223 CGEM, ITOS, INBX, VERV 13F-HR 11/14/2022 000095012322011895
Q2 2022 37 359,998 CGEM, ITOS, RPTX, MRUS 13F-HR 8/11/2022 000095012322008475
Q1 2022 37 372,610 CGEM, ITOS, MRUS, RPTX 13F-HR 5/13/2022 000095012322005661
Q4 2021 33 548,527 CGEM, ITOS, RPTX, MEIP 13F-HR 2/11/2022 000095012322002162
Q3 2021 33 644,676 CGEM, ITOS, RPTX, HOWL 13F-HR 11/15/2021 000095012321015022
Q2 2021 14 608,714 CGEM, ITOS, TCRR, RPTX 13F-HR 8/13/2021 000095012321010730
Q1 2021 13 795,909 CGEM, HARP, ITOS, TCRR 13F-HR 5/13/2021 000095012321006277
Q4 2020 13 569,376 TCRR, RPTX, ITOS, ONCR 13F-HR/A 2/24/2021 000095012321003117
Q4 2020 16 588,506 TCRR, RPTX, ITOS, ONCR 13F-HR 2/16/2021 000095012321002268
Q3 2020 12 415,058 RPTX, TCRR, HARP, ITOS RESTATEMENT 11/19/2020 000095012320012277
Q2 2020 11 376,116 RPTX, HARP, TCRR, MEI Pharma, Inc. 13F-HR 8/12/2020 000095012320008310
Q1 2020 10 163,704 HARP, EPZM, TCRR, GTHX 13F-HR 5/13/2020 000095012320004648
Q4 2019 12 282,172 HARP, EPZM, TCRR, GTHX 13F-HR 2/14/2020 000095012320002404
Additional filings from Mpm Bioimpact LLC that have since been restated